1 – 50 of 247
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cardiovascular disease risk in early rheumatoid arthritis : the impact of cartilage oligomeric matrix protein (COMP) and disease activity
(
- Contribution to journal › Article
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
- 2022
-
Mark
VEXAS : Medicinhistorisk kommentar apropå inslaget "UR VARDAGEN" i Reumabulletinen 151, 1/2022
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2021
-
Mark
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study
(
- Contribution to journal › Article
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
(
- Contribution to journal › Article
-
Mark
Apolipoprotein E triggers complement activation in joint synovial fluid of rheumatoid arthritis patients by binding C1q
(
- Contribution to journal › Article
-
Mark
Reumatologi? Nej tack, men man kan ju ändra sig!
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2019
-
Mark
Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article
- 2017
-
Mark
Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy
(
- Contribution to journal › Article
-
Mark
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
(
- Contribution to journal › Article
-
Mark
Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies
(
- Contribution to journal › Article
-
Mark
Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays
(
- Contribution to journal › Article
-
Mark
Indelning av de reumatiska sjukdomarna
2017) p.41-47(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Differentialdiagnostik vid ledsymtom
2017) p.91-97(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vad är reumatologi?
2017) p.21-24(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
-
Mark
Activation of complement by pigment epithelium-derived factor in rheumatoid arthritis
(
- Contribution to journal › Article
- 2016
-
Mark
Diet induced arthritis in pigs: Comment on the Article by Scher et al.
(
- Contribution to journal › Letter
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
-
Mark
Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective
(
- Contribution to journal › Article
-
Mark
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis
(
- Contribution to journal › Article
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
Universitetsenheterna i reumatologi i Lund och Malmö : Historia med Ido
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Metotrexat - Cellgiftet som blev basterapi vid reumatoid artrit
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal : A Prospective Observational Cohort Study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Limited impact of fibromodulin deficiency on the development of experimental skin fibrosis
2016) In Experimental Dermatology(
- Contribution to journal › Article
- 2015
-
Mark
Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C
(
- Contribution to journal › Article
-
Mark
Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years - relation to disease activity, joint damage and comorbidity.
(
- Contribution to journal › Article
-
Mark
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
(
- Contribution to journal › Article
-
Mark
Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.
(
- Contribution to journal › Letter
-
Mark
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
(
- Contribution to journal › Article
-
Mark
Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
(
- Contribution to journal › Article
- 2014
-
Mark
Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.
(
- Contribution to journal › Article
-
Mark
Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort
(
- Contribution to journal › Article
-
Mark
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjogren's syndrome and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Novel COMP Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases using Affinity Chromatography and Mass Spectrometry.
(
- Contribution to journal › Article
-
Mark
Articular cartilage
2014) p.33-41(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Relationships amongst osteoarthritis biomarkers, dynamic knee joint load, and exercise: results from a randomized controlled pilot study
(
- Contribution to journal › Article
-
Mark
Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article